a16z Podcast: The Economics of Expensive Medicines

a16z Podcast: The Economics of Expensive Medi...

Up next

Andrew Huberman’s Three Rules for Better Health and Focus

If you could do only three things for your health, what should they be? Andrew Huberman’s answer is surprisingly straightforward: get bright light shortly after waking, resistance train, and make the sleep you can get as high-quality as possible.Andrew joins a16z General Partner ...  Show more

John and Patrick Collison on Stripe's Growth, Agent Commerce, and the Future of Software

This interview with Stripe cofounders John and Patrick Collison originally aired on TBPN. They discuss Stripe's 34% growth and new employee tender offer, how agent commerce and stablecoins may require high-throughput blockchains built for millions of transactions per second, and ...  Show more

Recommended Episodes

73. Who Pays for Multimillion-Dollar Miracle Cures?
Freakonomics, M.D.

The most expensive drugs in the world are treatments for genetic diseases. And more of these cures are on the horizon. How will anyone be able to afford them? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal da ...  Show more

How to Buy DRUGS: The Finances of the Pharmaceutical Industry with Hitha Palepu
Networth and Chill with Your Rich BFF

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ...  Show more

How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more